This past summer, Leize and I spent a lot of time in British Columbia. In fact, if you are following my live videos on Facebook, you might recall several entries that called attention to the massive fires that were raging through both the B.C mainland and Vancouver Island. While fires in the Northwest are not uncommon, this year’s events were unprecedented in terms of their scope and duration.
As I pondered the reasons for what we were observing, I naturally defaulted to the idea that, front and center, this was yet another manifestation of climate change. But just this morning I learned that there is another sinister player that appears to be be playing a major role in increasing the frequency and intensity of these wildfires.
By: Austin Perlmutter, M.D.
Electronic cigarettes (commonly known as e-cigarettes) are a relatively new phenomenon. They’ve been discussed by some as a safer alternative to regular cigarettes, and have seen massive spikes in popularity over the last several years. Like many new technologies, it’s taken a bit of time for research to catch up with marketing. Unfortunately, this window has allowed for an incredible surge in e-cigarette use within one of our most vulnerable populations.
In November of 2018, the CDC released a report on e-cigarette use in American youth. The results show an epidemic, with 1 in 5 high school students and 1 in 20 middle school students using these products this year. These shocking statistics show that e-cigarette users increased from 1.5% of high school students in 2011 to 20.8% in 2018. Even more shocking, the total number of high schoolers using e-cigarettes increased by 78% from 2017 to 2018. Continue reading
While there certainly are various medications that prove somewhat helpful in the treatment of symptoms associated with Parkinson’s disease, it’s important to recognize that these medications are not actually treating the underlying disease itself.
We now understand that one of the pivotal mechanisms in Parkinson’s disease is the compromise of energy production at the mitochondrial level. This ultimately manifests as various problems, not just in the brain but throughout the entire body. With this understanding, specifically targeting mitochondrial function makes sense as a way of addressing this fundamental and underlying abnormality in Parkinson’s. Continue reading
It’s becoming quite common these days to see news releases documenting the failure of yet another experimental drug for the treatment of Alzheimer’s disease. In fact, one major pharmaceutical company, Pfizer, indicated in February of this year that they were no longer going to pursue efforts to develop a drug to treat this disease, which is now reaching epidemic proportions.
That said, millions of Americans are already taking medication that is FDA approved, to “treat” their Alzheimer’s disease. Since these medications are FDA approved, one would expect that they’ve been extensively tested and proven not only safe, but effective as well. Continue reading
I’ve often been quoted as stating that there is no pharmaceutical approach that has meaningful effectiveness on the treatment of Alzheimer’s disease. Unfortunately, I have to continue to make this claim. As was recently reported in the journal Neurology:
Despite great scientific efforts to find treatments for Alzheimer’s disease (AD), only 5 medications are marketed, with limited beneficial effects on symptoms, on a limited proportion of patients, without modification of disease course. The prevalence of AD doubles every 5 years reaching an alarming rate of 50% in those aged 85 years and older. In the context of the demographic trends of modern society, where the elderly are the fastest growing segment of the population, identification of new therapeutic targets that may prevent, delay, or cure AD is critically needed. (italics added).
The authors reemphasize what we know: that there is no silver bullet available now, or in the foreseeable future, that will help with this devastating and fatal condition. Continue reading
I’m sure many of you are familiar with Dave Asprey. He’s the founder of Bulletproof, and also a New York Times bestselling author. In addition, he hosts the very popular Bulletproof Radio podcast. On his podcast, Dave has had the opportunity to interview hundreds of thought leaders across a wide spectrum of disciplines and as such, he’s learned a lot. Continue reading
Asthma is the world’s most common respiratory disorder, and, studies have found, is often associated with increased rates of mortality and decreased quality of life. Thus, it’s obvious that keeping asthma at bay is in our collective best interests. Continue reading
By: The Dr. Perlmutter Team
As I’ve stated before, one of the most fascinating things about the human brain is that neuroplasticity, the process by which the brain undergoes changes in response to internal and external stimuli, affords us a great deal of control in determining the overall health of our brain. While there are many lifestyle changes one can make to improve overall brain health, studies have shown that dietary factors can have a significant impact. Choosing which foods you use to fuel your body goes far beyond counting calories; the macronutrients—fats, proteins, and carbohydrates—you emphasize in shaping your diet can have major repercussions for brain health. There is evidence to suggest that individuals who consume a diet high in carbohydrates have an 89% increased risk of developing dementia, while people who consume a diet high in healthy fats actually reduce their risk by 44%. Ensuring that the foods you consume are high in antioxidants, rich in healthy fats, low in carbohydrates, and powerfully anti-inflammatory can go a long way towards optimizing brain health and boosting memory and cognition.
Foods to Improve Brain Health and Memory
Generally speaking, I recommend a diet that is higher in fat and fiber, low in carbs, and rich in gut-healthy probiotics. To that end, please read on for some suggestions on specific foods around which to build a brain-boosting diet!